Search

Your search keyword '"Lyon, G. Marshall"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Lyon, G. Marshall" Remove constraint Author: "Lyon, G. Marshall" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
300 results on '"Lyon, G. Marshall"'

Search Results

1. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.

2. Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act

5. Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans

6. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

7. Ebola Virus Persistence in Semen of Male Survivors

8. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

9. Human Ebola virus infection results in substantial immune activation

12. PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study

16. Unrecognized Pretransplant and Donor-Derived Cryptococcal Disease in Organ Transplant Recipients

17. Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

18. Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

19. Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis

21. Cryptococcus neoformans in Organ Transplant Recipients: Impact of Calcineurin-Inhibitor Agents on Mortality

23. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

25. Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States

27. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006

28. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

31. Epidemiology of community-onset candidemia in Connecticut and Maryland

32. Bioaerosol sampling of a ventilated patient with COVID-19

35. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors

36. Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States

37. Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy.

38. Transmission of Eastern Equine Encephalitis Virus from an Organ Donor to Three Transplant Recipients

40. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality

41. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors.

43. New filovirus disease classification and nomenclature

45. HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV

47. New Lineage of Lassa Virus, Togo, 2016

48. Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy.

49. Activated macrophages as pathogenesis factors in Ebola virus disease in humans

50. New Lineage of Lassa Virus, Togo, 2016

Catalog

Books, media, physical & digital resources